参考文献/References:
［1］ 王 磊， 刘福全， 岳振东， 赵洪伟. 应用介入技术建立猪肝硬化门脉高压模型的实验研究［J］. 介入放射学杂志， 2012， 21： 756- 759.
［2］ Caprai S， Vajro P， Ventura A， et al. Autoimmune liver disease associated with celiac disease in childhood： a multicenter study［J］. Clin Gastroenterol Hepatol， 2008， 6： 803- 806.
［3］ Assy N， Kayal M， Mejirisky Y， et al. The changes in renal function after a single dose of intravenous furosemide in patients with compensated liver cirrhosis［J］. BMC Gastroenterol， 2006， 6： 39- 43.
［4］ Kuiper EM， Hansen BE， Lesterhuis W， et al. The long- term effect of ursodeoxycholic acid on laboratory liver parameters in biochemically non- advanced primary biliary cirrhosis［J］. Clin Res Hepatol Gastroenterol， 2011， 35： 29- 33.
［5］ Misik M， Hoelzl C， Wagner KH， et al. Impact of paper filtered coffee on oxidative DNA- damage： results of a clinical trial［J］. Mutat Res， 2010， 692： 42- 48.
［6］ Spahr L， Bresson- Hadni S， Amann P， et al. Allopurinol， oxidative stress and intestinal permeability in patients with cirrhosis： an open- label pilot study［J］. Liver Int， 2007， 27： 54- 60.
［7］ Simon- Talero M， Garcia- Martinez R， Torrens M， et al. Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy： a randomized double- blind study［J］. J Hepatol， 2013， 59： 1184- 1192.
［8］ Deng G， Wang J， Zhang Q， et al. Hepatoprotective effects of phloridzin on hepatic fibrosis induced by carbon tetrachloride against oxidative stress- triggered damage and fibrosis in rats［J］. Biol Pharm Bull， 2012， 35： 1118- 1125.
［9］ Fang H， Liu A， Dirsch O， et al. Liver transplantation and inflammation： is lipopolysaccharide binding protein the link? ［J］. Cytokine， 2013， 64： 71- 78.
［10］ Marotta F， Yoshida C， Barreto R， et al. Oxidative- inflammatory damage in cirrhosis： effect of vitamin E and a fermented papaya preparation［J］. J Gastroenterol Hepatol， 2007， 22： 697- 703.
［11］ Modi M， Goel T， Das T， et al. Ellagic acid & gallic acid from Lagerstroemia speciosa L. inhibit HIV- 1 infection through inhibition of HIV- 1 protease & reverse transcriptase activity［J］. Indian J Med Res， 2013， 137： 540- 548.
［12］ Ural MS， Yonar ME， Mise Yonar S. Protective effect of ellagic acid on oxidative stress and antioxidant status in Cyprinus carpio during malathion exposure［J］. Cell Mol Biol（Noisy- le- grand）， 2015， 61： 58- 63.
［13］ Mishra S， Vinayak M. Role of ellagic acid in regulation of apoptosis by modulating novel and atypical PKC in lymphoma bearing mice［J］. BMC Complement Altern Med， 2015， 15： 281
［14］ Zhang HM， Zhao L， Li H， et al. Research progress on the anticarcinogenic actions and mechanisms of ellagic acid［J］. Cancer Biol Med， 2014， 11： 92- 100.
［15］ De Minicis S， Brenner DA. Oxidative stress in alcoholic liver disease： role of NADPH oxidase complex［J］. J Gastroenterol Hepatol， 2008， 23（Suppl 1）： S98- S103.
［16］ Oettl K， Stadlbauer V， Petter F， et al. Oxidative damage of albumin in advanced liver disease［J］. Biochim Biophys Acta， 2008， 1782： 469- 473.
［17］ Vidali M， Occhino G， Ivaldi A， et al. Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol- drinking patients with chronic hepatitis C［J］. Am J Gastroenterol， 2008， 103： 147- 153.
［18］ Li J， Wang Y. Effect of different methods of hypoxic exercise training on free radical oxidation and antioxidant enzyme activity in the rat brain［J］. Biomed Rep， 2013， 1： 925- 929.
［19］ Yan Z， Qu K， Zhang J， et al. CD147 promotes liver fibrosis progression via VEGF- A/VEGFR2 signalling- mediated cross- talk between hepatocytes and sinusoidal endothelial cells［J］. Clin Sci （Lond）， 2015， 129： 699- 710.
［20］ Tekkesin N， Taga Y， Sav A， et al. Induction of HGF and VEGF in hepatic regeneration after hepatotoxin- induced cirrhosis in mice［J］. Hepatogastroenterology， 2011， 58： 971- 979.
［21］ Kishta SA， Abd- Alhade AA， Hamam O， et al. Prognostic value of TNF a mRNA and VEGF mRNA expression in patients with chronic hepatitis C genotype- 4， with and without cirrhosis and hepatocellular carcinoma to predict disease outcome［J］. J Egypt Soc Parasitol， 2010， 40： 515- 530.
［22］ Jaroszewicz J， Januszkiewicz M， Flisiak R， et al. Circulating vascular endothelial growth factor and its soluble receptors in patients with liver cirrhosis： possible association with hepatic function impairment［J］. Cytokine， 2008， 44： 14- 17.
［23］ Mukozu T， Nagai H， Matsui D， et al. Serum VEGF as a tumor marker in patients with HCV- related liver cirrhosis and hepatocellular carcinoma［J］. Anticancer Res， 2013， 33： 1013- 1021.
［24］ Surapaneni KM， Vishnu Priya V， Mallika J. Effect of pioglitazone， quercetin， and hydroxy citric acid on vascular endothelial growth factor messenger RNA（VEGF mRNA） expression in experimentally induced nonalcoholic steatohepatitis（NASH）［J］. Turk J Med Sci， 2015， 45： 542- 546.
［25］ Labrecque L， Lamy S， Chapus A， et al. Combined inhibition of PDGF and VEGF receptors by ellagic acid， a dietary- derived phenolic compound［J］. Carcinogenesis， 2005， 26： 821- 826.
［26］ Izawa T， Horiuchi T， Atarashi M， et al. Anti- fibrotic role of miR- 214 in thioacetamide- induced liver cirrhosis in rats［J］. Toxicol Pathol， 2015， 43： 844- 851.
［27］ Liu C， Wang G， Chen G， et al. Huangqi decoction inhibits apoptosis and fibrosis， but promotes Kupffer cell activation in dimethylnitrosamine- induced rat liver fibrosis［J］. BMC Complement Altern Med， 2012， 12： 51.
［28］ 初金哲， 王黎洲， 张 帅， 等. 改良的经大鼠胃十二指肠动脉逆行肝动脉插管实验研究［J］. 介入放射学杂志， 2016， 25： 798- 802.
相似文献/References:
[1]林立腾,蔡明岳,黄文薮,等.门静脉高压症小鼠模型构建 [J].介入放射学杂志,2018,27(03):242.
LIN Liteng,CAI Mingyue,HUANG Wensou,et al.The establishment of portal hypertension model in mice[J].journal interventional radiology,2018,27(04):242.